Multidisciplinary approach cuts symptoms of fibromyalgia

Multidisciplinary approach cuts symptoms of fibromyalgia
Multidisciplinary treatment adapted for women with low educational levels is superior to conventional pharmacotherapy in reducing key symptoms of fibromyalgia, including sleep disturbances, catastrophizing, and psychological distress, according to research published online Aug. 16 in Arthritis Care & Research.

(HealthDay)—Multidisciplinary treatment adapted for women with low educational levels is superior to conventional pharmacotherapy in reducing key symptoms of fibromyalgia (FM), including sleep disturbances, catastrophizing, and psychological distress, according to research published online Aug. 16 in Arthritis Care & Research.

Antoni Castel, of the University Hospital of Tarragona Joan XXIII in Spain, and colleagues conducted a randomized controlled trial of 155 women between the ages of 18 and 60 years with a diagnosis of FM to evaluate the efficacy of multidisciplinary treatment adapted for patients with low educational levels and to determine the durability of therapeutic benefit. One group received conventional pharmacologic treatment and the other group received multidisciplinary treatment, including pharmacologic treatment, education, physical therapy, and cognitive behavioral therapy (CBT).

The researchers found that, compared with the group receiving conventional , statistically significant improvement was noted in women in the multidisciplinary treatment group. Furthermore, the improvements in sleep disturbance, catastrophizing, and were maintained one year after treatment had ended.

"In conclusion, a multidisciplinary treatment program for FM that combines pharmacological treatment, education, physical therapy and CBT (the contents of which have been adapted for patients with low educational levels and applied in a group format in a non-hospital environment) has demonstrated efficacy in the treatment of the key symptoms of FM and the long-term maintenance of these improvements," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

New test could predict arthritis drug failure in patients

date Jul 03, 2015

A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings ...

About 8 percent of SLE patients have pulmonary HTN

date Jun 23, 2015

(HealthDay)—About 8 percent of patients with systemic lupus erythematosus (SLE) have pulmonary hypertension (PH), and serum uric acid (UA) has reasonable accuracy for predicting PH, according to a study ...

Early age of menopause linked to seropositivity in RA

date Jun 17, 2015

(HealthDay)—In women with early rheumatoid arthritis (RA), early age at menopause is associated with seropositivity, according to a study published in the May issue of Arthritis Care & Research.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.